象鼻支架术后远端胸或胸腹主动脉病变的开放与腔内治疗结局
总体30天死亡率6.3%,初始临床成功率88%,组间无差异。腔内组主要不良事件更低(20% vs 50%,P=0.047),5年辅助主要临床成功率更高(95% vs 68%,P=0.022),但再干预与总体生存相似。
要点
- FET后远端主动脉开放或腔内修复均可行,死亡与永久截瘫率可接受。
- 腔内修复围术期主要不良事件更低,主要因重度呼吸并发症更少。
- 腔内修复5年辅助主要临床成功率更高,但远期耐久性待更大队列验证。
核心结论
- FET后远端胸或胸腹主动脉病变行开放或腔内修复均可行,死亡率和永久截瘫率可接受。
- 腔内入路具有围术期和中期潜在优势,但长期耐久性需更大队列进一步研究。
研究设计与样本
- 回顾性队列研究,纳入2011至2020年48例(36例男性,中位年龄60岁)既往FET后行远端主动脉修复的患者。
- 评估死亡、心脏、肺、脑血管、肾及脊髓主要不良事件、早期与中期再干预和生存率,采用血管外科学会腔内报告标准。
主要发现
- 总体30天死亡率为6.3%,初始临床成功率为88%,组间无差异(P=0.22和0.66)。
- 记录6例脊髓功能障碍(13%),其中3例(6.3%)为永久性。
- 腔内组主要不良事件发生率更低[4例(20%) vs 14例(50%);P=0.047],主要因≥2级呼吸并发症更低(5% vs 42.9%;P=0.004)。
- 5年辅助主要临床成功率腔内组更高(95% vs 68%,P=0.022);竞争风险分析再干预无差异(P=0.3),Kaplan-Meier总体生存相似(log-rank P=0.29)。
临床怎么用
- 对既往FET后出现远端胸或胸腹主动脉病变的患者,开放与腔内修复均可作为可选方案。
- 腔内修复可能降低围术期主要不良事件(尤其重度呼吸并发症)并提高中期辅助主要临床成功率。
- 选择腔内修复时需权衡其长期耐久性尚未明确的问题。
局限性
- 样本量较小(48例),可能限制组间比较的统计效能。
- 为回顾性研究,存在选择偏倚可能。
- 长期耐久性需在更大队列中进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of this study was to evaluate the outcomes of open and endovascular treatment of downstream thoracic or thoraco-abdominal aortic pathology in patients who underwent previous frozen elephant trunk (FET). METHODS: Data were retrieved to evaluate mortality, cardiac, pulmonary, cerebrovascular, renal and spinal cord major adverse events, early- and mid-term reintervention and survival rates. The Society for Vascular Surgery endovascular reporting standards were used. RESULTS: From 2011 to 2020, 48 patients (36 males, median age 60 years) underwent downstream aortic repair at a median of 18 months (interquartile range: 6-57) after the initial FET. Twenty-eight patients (58.3%) received open and 20 (41.7%) endovascular repair. The overall 30-day mortality was 6.3% and the initial clinical success was 88%, with no inter-group differences (P = 0.22 and 0.66 respectively). Six spinal cord deficits were recorded (13%): 3 (6.3%) were permanent. The major adverse events incidence was lower in the endovascular cohort [4 (20%) vs 14 (50%); P = 0.047], mainly due to a lower rate of grade ≥2 respiratory complications (5% vs 42.9%; P = 0.004). Assisted primary clinical success at 5 years was higher in the endovascular group (95% vs 68%, P = 0.022); freedom from reintervention at competing risk analysis (P = 0.3) and overall survival at Kaplan-Meier curves (log-rank P = 0.29) were similar. CONCLUSIONS: Downstream aortic repair after FET is feasible with both open and endovascular repair with acceptable mortality and permanent paraplegia rates. The endovascular approach has potential perioperative and mid-term advantages, but long-term durability has to be further investigated in larger cohorts.
引用
- Loschi D, Melloni A, Grandi A, et al. Open or endovascular treatment of downstream thoracic or thoraco-abdominal aortic pathology after frozen elephant trunk: perioperative and mid-term outcomes. Eur J Cardiothorac Surg. 2021. PMID: 34355733. doi:10.1093/ejcts/ezab335
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。